Stocks and Investing
Stocks and Investing
Wed, January 31, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 30, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alex Arfaei of BMO Capital, Downgraded "AbbVie Inc." (ABBV) to Sell on, Jan 30th, 2018.
Alex has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018
- Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
- Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
This is the rating of the analyst that currently disagrees with Alex
- Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017